$FOLD Company News Apple sets intraday record; PetSmart

New Post Public Reply Private Reply Replies (0) Message Board

Aug 29, 2014 at 10:52 AM

$FOLD Company News

Apple sets intraday record; PetSmart considers sale 1:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 8:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 8:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 5:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 3:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 9:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 7:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 7:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 10:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 10:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 8:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 6:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 9:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 8:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 7:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 6:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 5:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 7:28 a.m. July 18, 2012 - MarketWatch.com
U.S. may end patents on DNA: report 1:13 p.m. Oct. 30, 2010 - Christopher Hinton
Monday's biggest gaining and declining stocks 4:51 p.m. Oct. 5, 2009 - MarketWatch

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog 9:49 a.m. Aug. 27, 2014 - Zacks.com
The Biotech Stock With The Best One-Week Performance 2:46 p.m. Aug. 25, 2014 - benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog 4:55 p.m. Aug. 21, 2014 - Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD) 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape 9:39 a.m. Aug. 21, 2014 - Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape 9:03 a.m. Aug. 21, 2014 - Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript) 3:43 p.m. Aug. 20, 2014 - Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:15 a.m. Aug. 20, 2014 - benzinga.com
Amicus Fabry disease drug candidate successful in Phase 3 trial 7:27 a.m. Aug. 20, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:10 a.m. Aug. 20, 2014 - benzinga.com
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win 6:01 a.m. Aug. 20, 2014 - TheStreet.com
Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript 9:37 p.m. Aug. 7, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:07 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape 8:44 a.m. Aug. 6, 2014 - Zacks.com
Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape 11:11 a.m. July 29, 2014 - Zacks.com
Applied Genetic Technologies Corporation (AGTC) Looks Strong as Stock Surges 15.3% - Tale of the Tape 8:44 a.m. July 28, 2014 - Zacks.com
Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape 8:44 a.m. July 25, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Jumps: Stock Rises 7.1% - Tale of the Tape 9:39 a.m. July 24, 2014 - Zacks.com

Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 8:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 6:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 4:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 8:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 2:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 6:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 7:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 8:20 a.m. June 4, 2014 - PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference 4:10 p.m. May 14, 2014 - GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. May 5, 2014 - GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive Conference 10:30 a.m. May 5, 2014 - BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Amicus Therapeutics to Announce First Quarter 2014 10:01 a.m. May 1, 2014 - GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011 6:01 a.m. April 29, 2014 - GlobeNewswire
Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference 4:39 p.m. March 27, 2014 - GlobeNewswire
Amicus Therapeutics Announces Full-Year 2013 Financial Results and Corporate Updates 5:01 p.m. March 3, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Catalina Behavioral Health: 4 Years, 1,000 Lives Touched

Pioneering Care in Behavioral Health Catalina Behavioral Health is proving that four years can make a difference. From their base in Tucson, they've grown to serve 1,000 souls navigating the stormy waters of addiction and mental health. It's not just about numbers, you see—this milestone marks real lives changed, one battle at a time. Building Trust, One Patient at a...

FSC Revives Frank Lloyd Wright's Planetarium Magic

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Decision Logic Innovates with Vitals & ShiftFlow Tools

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Navigating Hit and Run Protocols in St. Tammany Parish

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Amy Wilson Joins ITSA Board: A New Era for UBI?

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

Key Insights for Launching a Mobile Grooming Biz

Riding the Mobile Revolution with Grooming Anyone who's dabbled in grooming knows that moving to a mobile setup isn’t just about freedom and flexibility—it's a whole new ballgame. We're talking Chris Hanvey-level insights here, direct from Easley, S.C. This ain't your average jump in a van and snip some fur operation. Choosing the Right Rig First on the list: the...

1.8M Moves in England: The Admin Maze Explained

Navigating the Address Change Labyrinth Every time that welcome mat rolls out in a new spot, you're signing up for a mountain of paperwork. Sloth Move just painted a picture of the administrative mess awaiting those 1.8 million English households that decided 'new view, new digs' last year. Their analysis highlights why moving home means more than packing boxes—it's...

PhoenixAI and Cloudera's Strategic Partnership Shifts Data Landscape

Time to Embrace Change: PhoenixAI Teams with Cloudera Mention the word 'partnership' in the tech space, and it's often as common as a cup of joe at dawn—but this one truly shakes things up. We're talking about PhoenixAI hitching its wagon to Cloudera's startup circus, a merging of fire and steel in AI-driven database management. With PhoenixAI strutting its stuff on the...

Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

AMD CEO, Global Leaders Converge At IMPERIA Summit

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...